{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "16009521", "DateCompleted": {"Year": "2005", "Month": "09", "Day": "27"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "10"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0378-8741", "JournalIssue": {"Volume": "100", "Issue": "1-2", "PubDate": {"Year": "2005", "Month": "Aug", "Day": "22"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "Plants as a source of anti-cancer agents.", "Pagination": {"StartPage": "72", "EndPage": "79", "MedlinePgn": "72-9"}, "Abstract": {"AbstractText": ["Plant-derived compounds have been an important source of several clinically useful anti-cancer agents. These include vinblastine, vincristine, the camptothecin derivatives, topotecan and irinotecan, etoposide, derived from epipodophyllotoxin, and paclitaxel (taxol A number of promising new agents are in clinical development based on selective activity against cancer-related molecular targets, including flavopiridol and combretastin A4 phosphate, while some agents which failed in earlier clinical studies are stimulating renewed interest."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, P.O. Box B, Frederick, MD 21702-1201, USA. cragg@mail.nih.gov"}], "Identifier": [], "LastName": "Cragg", "ForeName": "Gordon M", "Initials": "GM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Newman", "ForeName": "David J", "Initials": "DJ"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "NumberOfReferences": "28"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2005", "Month": "5", "Day": "18"}, {"Year": "2005", "Month": "7", "Day": "13", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "9", "Day": "28", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "7", "Day": "13", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["16009521", "10.1016/j.jep.2005.05.011", "S0378-8741(05)00325-9"]}}], "PubmedBookArticle": []}